752 related articles for article (PubMed ID: 23244584)
21. Functions of neutral ceramidase in the Golgi apparatus.
Sakamoto W; Coant N; Canals D; Obeid LM; Hannun YA
J Lipid Res; 2018 Nov; 59(11):2116-2125. PubMed ID: 30154232
[TBL] [Abstract][Full Text] [Related]
22. Therapeutic potential of targeting ceramide/glucosylceramide pathway in cancer.
Kartal Yandım M; Apohan E; Baran Y
Cancer Chemother Pharmacol; 2013 Jan; 71(1):13-20. PubMed ID: 23073611
[TBL] [Abstract][Full Text] [Related]
23. New signalling pathway involved in the anti-proliferative action of vitamin D₃ and its analogues in human neuroblastoma cells. A role for ceramide kinase.
Bini F; Frati A; Garcia-Gil M; Battistini C; Granado M; Martinesi M; Mainardi M; Vannini E; Luzzati F; Caleo M; Peretto P; Gomez-Muñoz A; Meacci E
Neuropharmacology; 2012 Sep; 63(4):524-37. PubMed ID: 22579669
[TBL] [Abstract][Full Text] [Related]
24. An overview of sphingolipid metabolism: from synthesis to breakdown.
Gault CR; Obeid LM; Hannun YA
Adv Exp Med Biol; 2010; 688():1-23. PubMed ID: 20919643
[TBL] [Abstract][Full Text] [Related]
25. Targeting ceramide metabolism--a strategy for overcoming drug resistance.
Senchenkov A; Litvak DA; Cabot MC
J Natl Cancer Inst; 2001 Mar; 93(5):347-57. PubMed ID: 11238696
[TBL] [Abstract][Full Text] [Related]
26. Altered sphingolipid metabolism in human endometrial cancer.
Knapp P; Baranowski M; Knapp M; Zabielski P; Błachnio-Zabielska AU; Górski J
Prostaglandins Other Lipid Mediat; 2010 Jun; 92(1-4):62-6. PubMed ID: 20226264
[TBL] [Abstract][Full Text] [Related]
27. Sphingolipid pathway enzymes modulate cell fate and immune responses.
Molino S; Tate E; McKillop WM; Medin JA
Immunotherapy; 2017 Nov; 9(14):1185-1198. PubMed ID: 29067886
[TBL] [Abstract][Full Text] [Related]
28. The sphingolipid salvage pathway in ceramide metabolism and signaling.
Kitatani K; Idkowiak-Baldys J; Hannun YA
Cell Signal; 2008 Jun; 20(6):1010-8. PubMed ID: 18191382
[TBL] [Abstract][Full Text] [Related]
29. Ceramide synthesis and metabolism as a target for cancer therapy.
Reynolds CP; Maurer BJ; Kolesnick RN
Cancer Lett; 2004 Apr; 206(2):169-80. PubMed ID: 15013522
[TBL] [Abstract][Full Text] [Related]
30. Ceramidases, roles in sphingolipid metabolism and in health and disease.
Coant N; Sakamoto W; Mao C; Hannun YA
Adv Biol Regul; 2017 Jan; 63():122-131. PubMed ID: 27771292
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of bioactive sphingolipids in 4-HPR-resistant leukemia cells.
Apraiz A; Idkowiak-Baldys JK; Boyano MD; Pérez-Yarza G; Hannun YA; Asumendi A
BMC Cancer; 2011 Nov; 11():477. PubMed ID: 22061047
[TBL] [Abstract][Full Text] [Related]
32. The unfolding role of ceramide in coordinating retinoid-based cancer therapy.
Ghandour B; Dbaibo G; Darwiche N
Biochem J; 2021 Oct; 478(19):3621-3642. PubMed ID: 34648006
[TBL] [Abstract][Full Text] [Related]
33. Acid Ceramidase: A Novel Therapeutic Target in Cancer.
Vijayan Y; Lankadasari MB; Harikumar KB
Curr Top Med Chem; 2019; 19(17):1512-1520. PubMed ID: 30827244
[TBL] [Abstract][Full Text] [Related]
34. Control of metabolism and signaling of simple bioactive sphingolipids: Implications in disease.
Gangoiti P; Camacho L; Arana L; Ouro A; Granado MH; Brizuela L; Casas J; Fabriás G; Abad JL; Delgado A; Gómez-Muñoz A
Prog Lipid Res; 2010 Oct; 49(4):316-34. PubMed ID: 20193711
[TBL] [Abstract][Full Text] [Related]
35. Synthetic, non-natural sphingolipid analogs inhibit the biosynthesis of cellular sphingolipids, elevate ceramide and induce apoptotic cell death.
Dagan A; Wang C; Fibach E; Gatt S
Biochim Biophys Acta; 2003 Sep; 1633(3):161-9. PubMed ID: 14499735
[TBL] [Abstract][Full Text] [Related]
36. Sphingolipid signaling pathways as potential therapeutic targets in gliomas.
Van Brocklyn JR
Mini Rev Med Chem; 2007 Oct; 7(10):984-90. PubMed ID: 17979800
[TBL] [Abstract][Full Text] [Related]
37. Sphingosine-1-phosphate phosphohydrolase in regulation of sphingolipid metabolism and apoptosis.
Le Stunff H; Galve-Roperh I; Peterson C; Milstien S; Spiegel S
J Cell Biol; 2002 Sep; 158(6):1039-49. PubMed ID: 12235122
[TBL] [Abstract][Full Text] [Related]
38. Disruption of sphingolipid metabolism augments ceramide-induced autophagy in preeclampsia.
Melland-Smith M; Ermini L; Chauvin S; Craig-Barnes H; Tagliaferro A; Todros T; Post M; Caniggia I
Autophagy; 2015 Apr; 11(4):653-69. PubMed ID: 25853898
[TBL] [Abstract][Full Text] [Related]
39. The Role of Ceramide and Sphingosine-1-Phosphate in Alzheimer's Disease and Other Neurodegenerative Disorders.
Czubowicz K; Jęśko H; Wencel P; Lukiw WJ; Strosznajder RP
Mol Neurobiol; 2019 Aug; 56(8):5436-5455. PubMed ID: 30612333
[TBL] [Abstract][Full Text] [Related]
40. Updates on sphingolipids: Spotlight on retinopathy.
Shiwani HA; Elfaki MY; Memon D; Ali S; Aziz A; Egom EE
Biomed Pharmacother; 2021 Nov; 143():112197. PubMed ID: 34560541
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
